NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 82 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $23,550,000 | -27.9% | 1,194,237 | +6.2% | 6.12% | +3.6% |
| Q1 2021 | $32,682,000 | +7.3% | 1,124,237 | +11.8% | 5.91% | -6.7% |
| Q4 2020 | $30,463,000 | +88.0% | 1,005,534 | -1.3% | 6.33% | +269.2% |
| Q3 2020 | $16,202,000 | -25.1% | 1,018,334 | -7.0% | 1.72% | -60.7% |
| Q2 2020 | $21,619,000 | +67.4% | 1,095,184 | +4.6% | 4.36% | -13.4% |
| Q1 2020 | $12,912,000 | – | 1,047,184 | – | 5.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |